VeriMomcordyceps sinensis mycelium extract hamilelikte güvenli mi?
No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
Related ingredients
Frequently asked questions
- cordyceps sinensis mycelium extract hamilelikte güvenli mi?
- No harmonised CLP classification (ECHA Annex VI) or SCCS/CIR safety assessment identifying reproductive or developmental toxicity for Cordyceps sinensis mycelium extract. Peer‑reviewed literature on Cordyceps reports bioactive constituents (e.g., cordycepin) with various pharmacologic effects, but no consistent animal or human reproductive/developmental toxicity data were identified to indicate a reproductive hazard. Dermal exposure from cosmetics may give low but measurable systemic exposure to small molecules in extracts (hence e=1). Sources consulted: ECHA Annex VI (no entry), PubMed, PubChem, CosIng, EWG.
- cordyceps sinensis mycelium extract emzirirken güvenli mi?
- No evidence from regulatory listings or authoritative safety assessments (CIR/SCCS/ECHA Annex VI) of transfer into breastmilk or lactation-specific toxicity. Mechanistic data indicating placental or milk transfer are lacking; therefore no mechanistic concern is assigned. Low but measurable systemic absorption is possible from topical use, so exposure to nursing mother is considered low (e=1). Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- cordyceps sinensis mycelium extract bebek cildi için güvenli mi?
- No infant-specific reproductive or developmental toxicity data were identified and no regulatory flags for developmental toxicity exist. Mechanistic concerns for infant skin are not identified. Because infant skin has higher surface‑area‑to‑weight and a less mature barrier, exposure score is increased by +1 relative to adult (adult e=1 → baby e=2) to reflect higher potential per‑kg uptake from topical application of extracts containing small molecules. Sources: PubMed, PubChem, CosIng, ECHA Annex VI, EWG.
- VeriMom cordyceps sinensis mycelium extract nasıl puanlıyor?
- VeriMom cordyceps sinensis mycelium extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 93/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte cordyceps sinensis mycelium extract yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.